Phone-Delivered Behavioral Activation to Prevent Depression After Stroke
Tests phone-delivered behavioral activation by lay counselors in older stroke survivors with mild depression symptoms.
Plain-language title generated from the registry record
Registry title: Behavioral Activation for the PreVention of Post-strokE Depression in LoW-incomE Older Stroke Survivors
Key facts
- Where
- Houston, United StatesSee the site
Where in United States
- The University of Texas Health Science Center at HoustonHouston, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- The University of Texas Health Science Center, Houston
- Trial code
- NCT06864715
- Record updated
- 28 April 2026
- Original description
The overall objective of the project is to determine the effectiveness of tele-delivered behavioral activation (BA) by trained lay counselors (Tele-BA-S) to prevent Post-stroke depression (PSD) in low-income, older stroke survivors with subthreshold depression (SD).Read full original descriptionShow less
Behavioral Activation for the PreVention of Post-strokE Depression in LoW-incomE Older Stroke Survivors (LIVE-WEL)
The overall objective of the project is to determine the effectiveness of tele-delivered behavioral activation (BA) by trained lay counselors (Tele-BA-S) to prevent Post-stroke depression (PSD) in low-income, older stroke survivors with subthreshold depression (SD).
Inclusion: Enrollment within 3-months +2 weeks of a first-time ischemic or hemorrhagic stroke; 24-item HDRS score < 15 indicating subthreshold depression defined as the absence of depressive symptoms or presence of mild symptoms of depression; Single person income less than or equal to $45,000; Residing in a community residence; Ability to speak and read in English or Spanish; Mini-MoCA score > or equal to 11.
Exclusion: Diagnosed dementia and/or currently taking cognitive enhancers, amyloid-targeting medications, or orexin receptor antagonists; high-risk alcohol or drug misuse; receiving medications for mood disorders and a change in dose or type within the last 4 weeks; Stroke event unrelated to vascular risk factors (e.g., drug use) or transient ischemic attack; high suicide risk or severe psychiatric illness (e.g., bipolar disorder and active psychosis) and/or actively taking antipsychotics; 24-item HDRS score > or equal to 15 indicating moderate to severe depression; Actively participating in psychotherapy; Patient Health Questionnaire 9 score > or equal to 10 and/or answers positive to Q9; Diagnosed aphasia and/or severe cognitive impairments.